Youya Nakazawa
4PUBLICATIONS
55CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jan 15, 2025
Broad-Spectrum Efficacy of CEACAM6-Targeted Antibody-Drug Conjugate with BET Protein Degrader in Colorectal, Lung, and Breast Cancer Mouse Models.Hiroyuki Kogai, Shuntaro Tsukamoto, Minaho Koga
|Jul 10, 2024
Inhibition of Notch4 Using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor Endothelium.Jason W-L Eng, Yu Kato, Yusuke Adachi
|Mar 12, 2024
Delivery of a BET protein degrader via a CEACAM6-targeted antibody-drug conjugate inhibits tumour growth in pancreatic cancer models.Youya Nakazawa, Masayuki Miyano, Shuntaro Tsukamoto
|Oct 24, 2022
ER-851, a Novel Selective Inhibitor of AXL, Overcomes Resistance to Antimitotic Drugs.Shuntaro Tsukamoto, Naoko Hata Sugi, Kyoko Nishibata
Pageof 1
Frequent Collaborators
2 joint publications
Shuntaro Tsukamoto
2 joint publications
Junji Matsui
2 joint publications
Yu Kato
2 joint publications
Hiroyuki Kogai
2 joint publications
Toshio Imai
2 joint publications
Tsuyoshi Akagi
1 joint publications
Naoko Hata Sugi
1 joint publications
Kunihito Gotoh
1 joint publications
Sayo Fukushima
1 joint publications
Takayuki Nakagawa
